Advisory

 Performing Controlled Acts

(July 21, 2015) This is a general advisory to all members of the College of Naturopaths of Ontario with respect to the performance of the controlled acts of administering a prescribed substance by injection or inhalation and prescribing, dispensing, compounding or selling a drug.

Under Part II (Controlled Acts) of the General Regulation, members of the College are not permitted to perform these controlled acts until such time as they have met the Standard of Practice for Prescribing. The Standard of Practice for Prescribing requires that a member must successfully complete the Ontario Prescribing and Therapeutics Course and Examination.

What does this mean?



Members may not administer any of the prescribed substances by inhalation, for example glutathione, or by injection, for example B12, until they have met the Standard of Practice. Similarly, the controlled act of prescribing a drug, such as Rauwolfia; dispensing a drug, such as Vitamin D over 1,000 IU per day; compounding a drug, such as folic acid over 1 mg per dose; or selling a drug, such as Colchicine; may not be performed until the Standard of Practice has been met.

While the College recognizes that some members may have incorporated some of these functions, such as administering B12 by injection, into their practice under the former Board of Directors of Drugless Therapy - Naturopathy, they are captured by the new regulatory framework and not permitted until the Standard of Practice for Prescribing has been met.

The College of Naturopaths of Ontario, as your authoritative voice of regulation in Ontario, has provided detailed information on its website about the controlled acts and the Standards of Practice. We invite all members to review that information by visiting www.collegeofnaturopaths.on.ca or by using any of the following links:

Compounding Drugs
Dispensing Drugs
Inhalation
Injection
Prescribing Drugs
Selling Drugs
Prescribing Standard of Practice

Sincerely yours,

College of Naturopaths of Ontario
Andrew Parr, CAE
Registrar & CEO